Insider trading

Period: 120 months Stock: IRON + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

164 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

164 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

164 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

164 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
164 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
164 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

164 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
5 Aug 2025
Bitterman Kevin Director · indirect
Sold on a plan
$24.08K 395 at 60.95
0.1%
Planned (10b5-1)
30 Jul 2025
Bitterman Kevin Director · indirect
Sold on a plan
$518.35K 8,492 at 61.04
1.3%
Planned (10b5-1)
24 Jul 2025
Bitterman Kevin Director · indirect
Sold at will
$797.23K 13,033 at 61.17
2.0%
Not planned
23 Jul 2025
Bitterman Kevin Director · indirect
Sold at will
$1.82M 29,837 at 60.97
4.4%
Not planned
18 Jul 2025
Bitterman Kevin Director · indirect
Sold at will
$40.59K 664 at 61.13
0.1%
Not planned
17 Jul 2025
Franchi Jean M. Chief Financial Officer
Sold on a plan
$119.83K 2,031 at 59.00
3.1%
Planned (10b5-1)
10 Jul 2025
Franchi Jean M. Chief Financial Officer
Sold on a plan
$115.00K 2,000 at 57.50
3.0%
Planned (10b5-1)
9 Jul 2025
Quisel John D Chief Executive Officer
Sold on a plan 2×
$1.93M 34,800 at 55.33
17.7%
Planned (10b5-1)
3 Jul 2025
Quisel John D Chief Executive Officer
Sold on a plan
$286.45K 5,200 at 55.09
3.1%
Planned (10b5-1)
16 Jun 2025
Franchi Jean M. Chief Financial Officer
Sold on a plan
$104.52K 2,000 at 52.26
2.9%
Planned (10b5-1)
6 Jun 2025
Savage William Jacob Chief Medical Officer
Sold on a plan
$149.80K 2,996 at 50.00
5.0%
Planned (10b5-1)
20 May 2025
Savage William Jacob Chief Medical Officer
Sold on a plan
$334.13K 6,677 at 50.04
10.1%
Planned (10b5-1)
2 May 2025
Savage William Jacob Chief Medical Officer
Sold on a plan
$105.37K 2,100 at 50.17
3.1%
Planned (10b5-1)
24 Mar 2025
Ashiya Mona Director · indirect
Sold at will 3×
$310.48K 5,738 at 54.11
3.0%
Not planned
24 Mar 2025
ORBIMED ADVISORS LLC Director · indirect
Sold at will 3×
$310.48K 5,738 at 54.11
3.0%
Not planned
21 Mar 2025
Ashiya Mona Director · indirect
Sold at will 3×
$540.59K 10,011 at 54.00
5.1%
Not planned
21 Mar 2025
ORBIMED ADVISORS LLC Director · indirect
Sold at will 3×
$540.59K 10,011 at 54.00
5.1%
Not planned
20 Mar 2025
Ashiya Mona Director · indirect
Sold at will 3×
$149.18K 2,762 at 54.01
1.4%
Not planned
20 Mar 2025
ORBIMED ADVISORS LLC Director · indirect
Sold at will 3×
$149.18K 2,762 at 54.01
1.4%
Not planned
19 Mar 2025
Ashiya Mona Director · indirect
Sold at will 3×
$2.14M 39,656 at 54.02
17.3%
Not planned
19 Mar 2025
ORBIMED ADVISORS LLC Director · indirect
Sold at will 3×
$2.14M 39,656 at 54.02
17.3%
Not planned
12 Mar 2025
Ashiya Mona Director · indirect
Sold at will 6×
$4.53M 83,182 at 54.45
30.0%
Not planned
12 Mar 2025
ORBIMED ADVISORS LLC Director · indirect
Sold at will 6×
$4.53M 83,182 at 54.45
30.0%
Not planned
11 Mar 2025
Ashiya Mona Director · indirect
Sold at will 3×
$1.46M 27,056 at 54.01
11.7%
Not planned
11 Mar 2025
ORBIMED ADVISORS LLC Director · indirect
Sold at will 3×
$1.46M 27,056 at 54.01
11.7%
Not planned
10 Mar 2025
Ashiya Mona Director · indirect
Sold at will 6×
$10.97M 202,146 at 54.29
49.2%
Not planned
10 Mar 2025
ORBIMED ADVISORS LLC Director · indirect
Sold at will 6×
$10.97M 202,146 at 54.29
49.2%
Not planned
18 Feb 2025
Quisel John D Chief Executive Officer
Sold at will
$304.23K 5,574 at 54.58
3.5%
Not planned
18 Feb 2025
Stephenson Pamela Chief Commercial Officer
Sold at will
$171.22K 3,137 at 54.58
4.3%
Not planned
18 Feb 2025
Franchi Jean M. Chief Financial Officer
Sold at will
$171.16K 3,136 at 54.58
4.3%
Not planned
18 Feb 2025
Savage William Jacob Chief Medical Officer
Sold at will
$89.40K 1,638 at 54.58
2.3%
Not planned
18 Feb 2025
Yu Jonathan Yen-Wen Chief Operating Officer
Sold at will
$87.87K 1,610 at 54.58
3.8%
Not planned
18 Feb 2025
Khara Rahul Chief Legal Officer
Sold at will
$63.37K 1,161 at 54.58
3.0%
Not planned
3 Feb 2025
Khara Rahul Chief Legal Officer
Sold on a plan 2×
$416.57K 7,500 at 55.54
34.8%
Planned (10b5-1)
2 Jan 2025
Khara Rahul Chief Legal Officer
Sold on a plan 3×
$470.66K 7,500 at 62.75
34.8%
Planned (10b5-1)
30 Dec 2024
Quisel John D Chief Executive Officer
Sold on a plan 2×
$806.06K 13,012 at 61.95
15.3%
Planned (10b5-1)
23 Dec 2024
Quisel John D Chief Executive Officer
Sold on a plan 3×
$1.25M 19,820 at 63.14
21.6%
Planned (10b5-1)
16 Dec 2024
Quisel John D Chief Executive Officer
Sold on a plan 4×
$844.31K 12,791 at 66.01
15.1%
Planned (10b5-1)
2 Dec 2024
Sold on a plan 3×
$126.49K 1,957 at 64.63
100%
Sold half or more
25 Nov 2024
Savage William Jacob Chief Medical Officer
Sold on a plan 3×
$928.33K 14,183 at 65.45
26.0%
Planned (10b5-1)
15 Nov 2024
Savage William Jacob Chief Medical Officer
Sold on a plan 3×
$546.15K 9,158 at 59.64
18.5%
Planned (10b5-1)
4 Nov 2024
Sold on a plan 2×
$418.21K 7,136 at 58.61
100%
Sold half or more
1 Nov 2024
Sold on a plan 2×
$9.32K 201 at 46.37
100%
Sold half or more
1 Oct 2024
Sold on a plan 4×
$10.31K 201 at 51.31
100%
Sold half or more
16 Sep 2024
Savage William Jacob Chief Medical Officer
Sold on a plan
$71.12K 1,500 at 47.41
3.6%
Planned (10b5-1)
3 Sep 2024
Sold on a plan 4×
$97.16K 1,957 at 49.65
100%
Sold half or more
3 Sep 2024
Savage William Jacob Chief Medical Officer
Sold on a plan
$75.89K 1,500 at 50.59
3.5%
Planned (10b5-1)
1 Aug 2024
Sold on a plan 2×
$8.73K 201 at 43.44
100%
Sold half or more
1 Jul 2024
Sold on a plan 3×
$9.25K 201 at 46.04
100%
Sold half or more
17 Jun 2024
Bitterman Kevin Director · indirect
Bought
$8.00M 222,223 at 36.00
112%
First buy on file
Showing 51–100 of 164. ← Newer Page 2 of 4 Older →